News about "Clinical Trials"

DHL Group Acquires CRYOPDP from Cryoport to Boost DHL Health Logistics

Going forward, DHL Supply Chain will further build the potential of its Pharma Specialized Network solution by leveraging the specialty courier expertise of newly acquired CRYOPDP and the global air capabilities of DHL Express and DHL Global Forwarding.

Clinical Trials | 05/04/2025 | By Aishwarya

Chance Pharma Receives New Funding to Develop Innovative Inhalation Therapies

Chance Pharma operates state-of-the-art production facilities compliant with FDA and EMA quality standards, underscoring its strong capabilities in both R&D and manufacturing.

Clinical Trials | 18/03/2025 | By Aishwarya

Advarra Launches Comprehensive Solution to Improve Collaboration on Clinical Trials

The new offering combines the Longboat technology acquired by Advarra in 2020, which now has over 225,000 users, with Advarra's study startup delivery program and industry-adopted single sign-on capabilities.

Clinical Trials | 22/01/2025 | By Aishwarya |  104

Biofidelity and CellCarta Announce Partnership to Enhance NSCLC Clinical Trials with Aspyre Lung

Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analysing both DNA and RNA from tissue and blood using a streamlined four-step workflow.

Clinical Trials | 17/01/2025 | By Abha

Unravel Biosciences and PECET to Conduct Clinical Trials of RVL-001 in Rett Syndrome in Colombia

Unravel's proprietary BioNAV drug discovery platform identified RVL-001 as a potentially promising therapeutic drug for Rett Syndrome and PTHS.

Clinical Trials | 25/10/2024 | By Aishwarya |  160

Grit Biotechnology Secures IND Clearance for GT201 from US FDA

GT201, an advanced genetically engineered TIL product developed by Grit Biotechnology's platforms StemTexp and StaViral, boosts T cell survival and function by expressing a vital membrane-bound cytokine complex.

Clinical Trials | 02/09/2024 | By Aishwarya |  171

Merck to Acquire CN201 from Curon Biopharmaceutical

CN201 is currently being evaluated in Phase 1 and Phase 1b/2 clinical trials for treating patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL) and relapsed or refractory B-cell acute lymphocytic leukemia (ALL), respectively.

Clinical Trials | 14/08/2024 | By Aishwarya |  146

Lexicon Selects Medidata to Advance First Non-Opioid Drug for Neuropathic Pain

Medidata has been chosen by Lexicon Pharmaceuticals, Inc. to help advance PROGRESS, a Phase 2b study of LX9211 in diabetic peripheral neuropathic pain (DPNP), with the potential for LX9211 to become the first new, non-opioid drug approved for neuropathic pain in over two decades.

Clinical Trials | 30/05/2024 | By Aishwarya |  143

Parexel Join Hands with Palantir to Boost Clinical Data Delivery for Patients

Parexel has forged a multi-year strategic partnership with Palantir Technologies Inc. to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers.

Clinical Trials | 29/04/2024 | By Aishwarya |  263

ENTOD Pharma Gets CDSCO Approval for PresVu to Treat Age-Related Vision Impairment

ENTOD Pharmaceuticals has gained approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.

Clinical Trials | 19/04/2024 | By Aishwarya |  516